共 42 条
[1]
Subramanian C.R., Triadafilopoulos G., Refractory gastroesophageal reflux disease, Gastroenterol Rep (Oxf), 3, 1, pp. 41-53, (2015)
[2]
Kamolz T., Pointner R., Expectations of patients with gastroesophageal reflux disease for the outcome of laparoscopic antireflux surgery, Surg Laparosc Endosc Percutan Tech, 12, 6, pp. 389-392, (2002)
[3]
Reimer C., Safety of long-term PPI therapy, Best Pract Res Clin Gastroenterol, 27, 3, pp. 443-454, (2013)
[4]
Hirano I., Richter J.E., Practice Parameters Committee of American College of Gastroenterology. ACG practice guidelines: esophageal reflux testing, Am J Gastroenterol, 102, pp. 668-685, (2007)
[5]
Yuan Y., Hunt R.H., Evolving issues in the management of reflux disease?, Curr Opin Gastroenterol, 25, 4, pp. 342-351, (2009)
[6]
Frazzoni M., Manno M., De Micheli E., Savarino V., Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors, Dig Liver Dis, 39, 5, pp. 415-421, (2007)
[7]
Lin D., Triadafilopoulos G. Dual ambulatory ph monitoring in patients with gastroesophageal reflux rendered asymptomatic with proton pump inhibitor therapy, Dig Dis Sci, 60, 5, pp. 1343-1349, (2015)
[8]
Galindo G., Vassalle J., Marcus S.N., Triadafilopoulos G., Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy, Dis Esophagus, 26, 5, pp. 443-450, (2013)
[9]
Frazzoni M., Piccoli M., Conigliaro R., Frazzoni L., Melotti G., Laparoscopic fundoplication for gastroesophageal reflux disease, World J Gastroenterol, 20, 39, pp. 14272-14279, (2014)
[10]
Roman S., Lin Z., Kwiatek M.A., Et al., Weak peristalsis in esophageal pressure topography: classification and association with dysphagia, Am J Gastroenterol, 106, pp. 349-356, (2011)